Astra Enters Obesity Drug Race With Chinese Biotech Deal
AstraZeneca Plc clinched a deal to develop a drug from the pharma industry’s hottest class of medicines, agreeing
1970-01-01 08:00
Japan’s Biggest Firms Set for $9.3 Billion Bonanza From Weak Yen
Ten of Japan’s biggest companies are likely to pocket an extra 1.4 trillion yen ($9.3 billion) in profits
1970-01-01 08:00
Merck Discontinues Developing Drug Candidates With Sichuan Kelun After Daiichi Sankyo Deal
Merck & Co. won’t continue with two drug candidates it previously agreed to co-develop with a Chinese biotech
1970-01-01 08:00
Asia Stocks Set For Losses as US Volatility Rises: Markets Wrap
Asian stocks are set to fall in early trading as the rout in US stocks and Treasuries deepened
1970-01-01 08:00
Daiichi Sankyo Leads Japan Pharma Stocks Higher on Cancer Drug
Daiichi Sankyo Co. shares jumped by the most in a year after a drug it developed with AstraZeneca
1970-01-01 08:00
Astra Strikes $1 Billion Gene Therapy Deal With Pfizer
AstraZeneca Plc has agreed to buy a portfolio of rare disease gene therapies from Pfizer Inc. as the
1970-01-01 08:00
New AstraZeneca Cancer Drug Shows Potential in Key Study
An AstraZeneca Plc cancer medicine showed a statistically significant improvement over standard chemotherapy in a high-level study. The
1970-01-01 08:00
AstraZeneca’s Japan Partner to Go Solo on Future Cancer Drugs
When Japanese pharmaceutical company Daiichi Sankyo Co. discovered a groundbreaking cancer treatment, it turned to bigger Western drugmaker
1970-01-01 08:00